Evidence map›Paper›PMID 35418192›Full record

ArticleScientific reports2022

Temporal reproducibility of IgG and IgM autoantibodies in serum from healthy women.

T V Clendenen, S Hu, Y Afanasyeva, M Askenazi, K L Koenig, T Hulett, M Liu, S Liu, F Wu, A Zeleniuch-Jacquotte and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

T V Clendenen *Department of Population Health, Division of Epidemiology, NYU Langone Health School of Medicine, 180 Madison Ave. 5th Floor, New York, NY, 10016, USA.
S Hu *CDI Laboratories, Baltimore, MD, USA.
Y AfanasyevaDepartment of Population Health, Division of Epidemiology, NYU Langone Health School of Medicine, 180 Madison Ave. 5th Floor, New York, NY, 10016, USA.
M AskenaziDepartment of Population Health, Division of Epidemiology, NYU Langone Health School of Medicine, 180 Madison Ave. 5th Floor, New York, NY, 10016, USA.
K L KoenigDepartment of Population Health, Division of Epidemiology, NYU Langone Health School of Medicine, 180 Madison Ave. 5th Floor, New York, NY, 10016, USA.
T HulettCDI Laboratories, Baltimore, MD, USA.
M LiuDepartment of Population Health, Division of Epidemiology, NYU Langone Health School of Medicine, 180 Madison Ave. 5th Floor, New York, NY, 10016, USA.
S LiuCDI Laboratories, Baltimore, MD, USA.
F WuDepartment of Population Health, Division of Epidemiology, NYU Langone Health School of Medicine, 180 Madison Ave. 5th Floor, New York, NY, 10016, USA.
A Zeleniuch-JacquotteDepartment of Population Health, Division of Epidemiology, NYU Langone Health School of Medicine, 180 Madison Ave. 5th Floor, New York, NY, 10016, USA.
Y ChenDepartment of Population Health, Division of Epidemiology, NYU Langone Health School of Medicine, 180 Madison Ave. 5th Floor, New York, NY, 10016, USA. yu.chen@nyulangone.org.
NYU Langone Health · USCDI Laboratories (United States) · PR

Funding

The NYU Women's Health StudyU01CA182934 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CHEN, YU · 2020 to 2023
$2.7M
NCI NIH HHS U01 CA182934NCI NIH HHS U01CA182934
6 · The paper itself

Abstract

Autoantibodies are present in healthy individuals and altered in chronic diseases. We used repeated samples collected from participants in the NYU Women's Health Study to assess autoantibody reproducibility and repertoire stability over a one-year period using the HuProt array. We included two samples collected one year apart from each of 46 healthy women (92 samples). We also included eight blinded replicate samples to assess laboratory reproducibility. A total of 21,211 IgG and IgM autoantibodies were interrogated. Of those, 86% of IgG (n = 18,303) and 34% of IgM (n = 7,242) autoantibodies showed adequate lab reproducibility (coefficient of variation [CV] < 20%). Intraclass correlation coefficients (ICCs) were estimated to assess temporal reproducibility. A high proportion of both IgG and IgM autoantibodies with CV < 20% (76% and 98%, respectively) showed excellent temporal reproducibility (ICC > 0.8). Temporal reproducibility was lower after using quantile normalization suggesting that batch variability was not an important source of error, and that normalization removed some informative biological information. To our knowledge this study is the largest in terms of sample size and autoantibody numbers to assess autoantibody reproducibility in healthy women. The results suggest that for many autoantibodies a single measurement may be used to rank individuals in studies of autoantibodies as etiologic markers of disease.

Indexed as

AutoantibodiesHealth StatusFemaleHumansImmunoglobulin GImmunoglobulin MReproducibility of ResultsAutoantibodiesImmunoglobulin GImmunoglobulin M

Identifiers

PMID35418192
PMCPMC9008031
OpenAlexW4223912559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.